Israel drugmakers are having a strong competitiveness in that sector.
Teva`s chart
| Reuters: "Israel's Teva (TEVA.TA) (TEVA.O) won the battle for generic drugmaker Ratiopharm, paying 3.7 billion euros ($5.1 billion) to fix its weakness in Germany, the world's second-largest generics market."
No comments:
Post a Comment